William Blair Has Optimistic Outlook of EHC FY2025 Earnings

Encompass Health Corporation (NYSE:EHC) – Investment analysts at William Blair upped their FY2025 earnings per share estimates for shares of Encompass Health in a research note issued to investors on Friday, October 31st. William Blair analyst J. Haase now anticipates that the company will earn $5.29 per share for the year, up from their previous estimate of $5.24. The consensus estimate for Encompass Health’s current full-year earnings is $4.80 per share. William Blair also issued estimates for Encompass Health’s Q1 2026 earnings at $1.51 EPS, Q2 2026 earnings at $1.44 EPS, Q3 2026 earnings at $1.42 EPS and Q4 2026 earnings at $1.35 EPS.

Several other research firms also recently issued reports on EHC. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Barclays boosted their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Stock Down 2.5%

Shares of NYSE EHC opened at $113.86 on Monday. Encompass Health has a 12-month low of $87.85 and a 12-month high of $127.99. The company has a market cap of $11.47 billion, a P/E ratio of 21.52, a P/E/G ratio of 2.20 and a beta of 0.93. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a fifty day moving average price of $124.22 and a 200 day moving average price of $119.10.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio is presently 14.37%.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Institutional Trading of Encompass Health

A number of institutional investors and hedge funds have recently made changes to their positions in EHC. Norges Bank acquired a new stake in shares of Encompass Health during the 2nd quarter worth approximately $139,536,000. Congress Asset Management Co. bought a new position in Encompass Health in the 2nd quarter worth about $92,691,000. 8 Knots Management LLC bought a new position in Encompass Health in the 2nd quarter worth about $78,644,000. Nuveen LLC bought a new position in Encompass Health in the 1st quarter worth about $50,665,000. Finally, T. Rowe Price Investment Management Inc. grew its position in Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after purchasing an additional 424,691 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.